Drugs / NeoPep Vaccine1
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05557240 | Sep 2022 → Feb 2024 | malignant glioma | Shanghai 10th People's Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NeoPep Vaccine1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05557240 ↗ |
| Modality | Vaccine | “NPVAC1 vaccine will be applied before maintenance TMZ cycles after completion of chemoradiation therapy (CRT)” NCT05557240 ↗ |